Atrandi Biosciences
Atrandi Biosciences develops microfluidic partitioning platforms — Onyx, Styx, and Flux — built around its patented Semi-Permeable Capsule technology for single-cell multi-omics research, serving academic and biotech/pharma customers globally with instruments, consumables, and sequencing services.
- Company typePrivate
- Founded2016
- HeadquartersVilnius, Lithuania
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Atrandi Biosciences does
Atrandi Biosciences is a Lithuanian life-sciences tools company, founded in 2016 in Vilnius as Droplet Genomics and rebranded in 2022, that develops microfluidic partitioning technologies for single-cell analysis. Its core technology is the Semi-Permeable Capsule (SPC) — a hydrogel-based microreactor that retains cells and nucleic acids while allowing free exchange of reagents, enabling multi-step and multi-omic workflows at single-cell resolution. The company holds three granted patents (US 11,860,076, US 11,958,947, and UK GB2616351), is ISO 9001 and ISO 14001 certified, and operates with 51-100 employees.
The company sells three instrument platforms: Onyx (a versatile microfluidic system), Styx (a high-throughput droplet sorter), and Flux (a streamlined SPC generator). These are complemented by a consumables catalog — SPC Innovator Kits, Microbial Whole-Genome Sequencing Kits, and microfluidic chips — plus custom microfluidic chip design and proof-of-concept sequencing services. The technology stack combines droplet microfluidics, optical detection, and embedded computer vision for compartment QC (up to 4000 fps, ML-based size analysis).
Atrandi serves academic research groups and biotechnology/pharmaceutical customers running single-cell genomics, microbial genomics, and functional screening, with a stated installed base of 150+ instruments and 200+ research groups across 20+ institutional partnerships. The revenue model is instruments plus recurring consumables, with US expansion — anchored by a new Chief Commercial Officer hire — as the near-term commercial priority. The company has raised approximately $30M+ across three venture rounds, most recently a $25M Series A in February 2025 led by Lux Capital with Microsoft participation.
Atrandi Biosciences firmographics
Firmographics- Name
- Atrandi Biosciences
- Legal name
- Atrandi Biosciences
- Website
- https://www.atrandi.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Atrandi Biosciences develops microfluidic partitioning platforms — Onyx, Styx, and Flux — built around its patented Semi-Permeable Capsule technology for single-cell multi-omics research, serving academic and biotech/pharma customers globally with instruments, consumables, and sequencing services.
- Ownership category
- akta.pro rank
Atrandi Biosciences industry classification
Industry- Product category
- Microfluidic Single-Cell Analysis Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industries
- Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI), Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)
Keywords
Where Atrandi Biosciences is headquartered
LocationHeadquarters
- HQ city
- Vilnius
- HQ country
- Lithuania
- HQ region
- Europe
Offices1 record
Markets served
Atrandi Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Microfluidic Instruments: Sale of specialized hardware platforms (Onyx, Styx, Flux) for microfluidic workflows and single-cell analysis. Instruments range from versatile research platforms to application-specific systems.
- Consumables and Kits: Recurring revenue from consumable kits including SPC Innovator Kits, Droplet Generation Kits, and Single-Cell Microbial WGS kits. Includes microfluidic chips, oils, reagents, and accessories.
- Proof of Concept Services: Proof of concept sequencing service where company processes customer samples through their workflow including cell encapsulation, barcoding, and sequencing on Illumina platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Pay-as-you-go | Single-Cell DNA & RNA Co-sequencing early access pricing |
| Other | Multi-year contract | Enterprise instrument pricing |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Atrandi Biosciences product offering
Product offeringCore offering
Atrandi Biosciences develops, manufactures, and sells microfluidic instruments (Onyx, Styx, Flux) and consumable kits built around its patented Semi-Permeable Capsule (SPC) technology for single-cell partitioning and multiomics workflows. The SPCs are hydrogel microreactors that retain cells and nucleic acids while permitting free exchange of reagents, enabling multi-step, multiomic processing on the same cell that is not possible with conventional droplet systems. The company also offers proof-of-concept sequencing services, custom microfluidic chip prototyping, and recurring reagent kits (SPC Innovator Kit, Single-Cell Microbial WGS Kit, dsDNA Barcoding Kit) used by academic and biopharma research laboratories globally.
Product overview
Atrandi Biosciences offers a platform-based ecosystem centered on Semi-Permeable Capsule (SPC) and droplet microfluidic technologies for single-cell analysis. The product portfolio comprises three instrument platforms: Onyx (versatile microfluidic platform for SPC and droplet generation with real-time imaging), Styx (high-throughput droplet sorting platform for fluorescence-activated droplet screening), and Flux (streamlined SPC generation for effortless single-cell isolation). Supporting these platforms are specialized reagent kits including the SPC Innovator Kit for custom workflow development, Single-Cell Microbial WGS Kit for microbial genomics, and dsDNA Barcoding Kit for sequencing applications. The ecosystem is complemented by microfluidic consumables (chips, oils, accessories) and custom chip prototyping services, enabling researchers to design and execute tailored single-cell multiomics workflows.
Differentiator
Problem solved
Functional benefit
Products and services
- Onyx Platform A versatile microfluidic platform enabling researchers to scale liquid handling to high-throughput levels using droplet and Semi-Permeable Capsule technologies, with intuitive syringe pump control, high-speed microscopy, active droplet manipulation, and machine learning-based in-line compartment size and occupancy analysis. Built for researchers developing custom droplet and SPC single-cell workflows.
- Styx Platform A high-throughput screening platform integrating multicolor fluorescence analysis, pressure pumps, and software for fluorescence-activated droplet sorting (FADS). Supports sorting rates up to 1000 Hz, 4 lasers (405/488/561/637 nm), dual high-speed cameras, and embedded UI for protein engineering, antibody discovery, and functional screening workflows.
- Flux Platform A streamlined SPC generation platform with push-button operation that encapsulates 100,000s of single cells into Semi-Permeable Capsules in 30 minutes and processes up to 8 samples simultaneously using disposable consumables. Designed for reproducible, application-specific single-cell analysis without requiring microfluidics expertise.
- SPC Innovator Kit A complete kit for robust cell isolation into Semi-Permeable Capsules with sizes from 30 µm to 300 µm, enabling seamless execution of multiple sample processing steps through simple pipetting while maintaining compartmentalization. Designed for researchers developing custom single-cell multi-step workflows.
- Single-Cell Microbial WGS Kit A kit barcoding up to 10,000 microbial single amplified genomes (SAGs) per experiment for high-quality microbial genome recovery. Optimized for Illumina short-read sequencing and adaptable to other NGS platforms, delivering strain-level taxonomic resolution at less than $1 per cell including sequencing.
- dsDNA Barcoding Kit An extension of the Innovator Kit for developing custom single-cell sequencing workflows that integrates with upstream molecular biology to distinctly barcode amplified dsDNA while preserving single-cell resolution.
- Microfluidic Kits and Consumables A portfolio of microfluidic kits and consumables including droplet generation kits, co-flow droplet generation kits, reagent addition kits, droplet merging kits, droplet selection kits, PDMS microfluidic chips in various channel sizes, and specialized oils (droplet stabilization oil, droplet spacing oil, sample loading oil, emulsion breaker) for SPC and droplet-based workflows.
- Custom Microfluidic Chip Prototyping Service A service offering custom microfluidic chip prototyping and manufacturing with fast turnaround, including chip design, photolithography template production, and PDMS chip manufacturing for researchers developing novel microfluidic workflows.
- Proof-of-Concept Sequencing Service A proof-of-concept sequencing service in which Atrandi processes customer samples through its workflow—including cell encapsulation, barcoding, and Illumina sequencing—often in partnership with bioinformatics providers such as the Single Cell Genomics Center at Bigelow Laboratory, for customers lacking in-house single-cell capabilities.
Quantifiable outcome
- Process up to 100,000 single cells in 30 minutes with Flux platform
- +3 more outcomes
Companies that use Atrandi Biosciences
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Atrandi Biosciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature6 records
Atrandi Biosciences partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and supporting.
- Single Cell Genomics Center at Bigelow LaboratorycorePartnership for advanced bioinformatics services for microbiologists. Provides data analysis support for customers lacking in-house bioinformatics resources. Includes proof of concept sequencing services.
- Seed BiosciencessupportingPartnership enabling precise transfer of selected cells from droplets into microwell plates for individual cultivation. Addresses challenge of single-cell isolation from selected droplets for cell line development.
Scale indicators8 records
Recent moves13 records
Expansion highlights6 records
Atrandi Biosciences competitors and assessment
Company assessmentDirect peers
- 10x Genomics: Dominant single-cell analysis platform provider offering Chromium instruments and consumables for genomics, transcriptomics, and multi-omics. Most direct competitor to Atrandi in single-cell partitioning and multi-omic workflows.
- Standard BioTools (formerly Fluidigm, merged with PhenomeX/Berkeley Lights): Provides microfluidics-based single-cell tools including mass cytometry and Beacon optofluidic screening. Direct competitor in microfluidic instrumentation for single-cell and functional screening applications.
- Parse Biosciences: Offers Evercode single-cell sequencing without requiring proprietary instruments, using combinatorial barcoding. Competes with Atrandi in single-cell transcriptomics, particularly for researchers seeking lower-cost alternatives.
- Mission Bio: Specializes in single-cell multi-omics for genomics, including Tapestri Platform for targeted DNA + protein analysis. Direct competitor in single-cell multi-omic capabilities overlapping with Atrandi's DNA/RNA co-sequencing applications.
- Sphere Bio: Provides picodroplet-based microfluidic instruments (e.g., Cyto-Mine) for single-cell functional screening and sorting. Direct peer in picodroplet/droplet microfluidic technology serving protein engineering and antibody discovery.
- Dolomite Bio (Blacktrace Holdings): Designs and manufactures microfluidic instruments and consumables for single-cell research, including the Nadia platform. Direct peer offering droplet microfluidic instrumentation to the same academic and biotech customer base.
Broad incumbents
- Bio-Rad Laboratories: Offers the ddSEQ single-cell sequencing workflow through partnership with Illumina, and operates a broad life science research tools portfolio. Competes with Atrandi in droplet-based single-cell genomics while serving much wider life science markets.
- BD Biosciences: Operates in single-cell analysis through flow cytometry, cell sorting, and related reagents via the BD FACSDiscover platform. Broad incumbent offering cell sorting capabilities adjacent to Atrandi's Styx droplet sorting.
- Bruker (acquired NanoString): Acquired NanoString's CosMx spatial biology platform and offers mass cytometry-based single-cell tools. Broad incumbent in single-cell and spatial omics competing with Atrandi's spatial-relevant single-cell applications.
Emerging players
- 1CellBio (now part of Cantata Bio): Offers single-cell analysis solutions including the inDrop microfluidic platform. Emerging player in single-cell genomics and immunology research, overlapping with Atrandi's academic customer use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Atrandi Biosciences social profiles
Digital presenceAtrandi Biosciences compliance and trust
Trust signalCompliance2 records
Atrandi Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Atrandi Biosciences leadership team
Management profileNumber of profiles
Profiles9 records
Atrandi Biosciences funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Atrandi Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Atrandi Biosciences
What does Atrandi Biosciences do?
Atrandi Biosciences develops, manufactures, and sells microfluidic instruments (Onyx, Styx, Flux) and consumable kits built around its patented Semi-Permeable Capsule (SPC) technology for single-cell partitioning and multiomics workflows. The SPCs are hydrogel microreactors that retain cells and nucleic acids while permitting free exchange of reagents, enabling multi-step, multiomic processing on the same cell that is not possible with conventional droplet systems. The company also offers proof-of-concept sequencing services, custom microfluidic chip prototyping, and recurring reagent kits (SPC Innovator Kit, Single-Cell Microbial WGS Kit, dsDNA Barcoding Kit) used by academic and biopharma research laboratories globally.
Is Atrandi Biosciences a public or private company?
Atrandi Biosciences is a private company. It is classified as venture growth investor backed and is currently operating.
When was Atrandi Biosciences founded?
Atrandi Biosciences was founded in 2016. It employs 51 to 100 people.
Where is Atrandi Biosciences based?
Atrandi Biosciences is headquartered in Vilnius, Lithuania, in the Europe region.
How does Atrandi Biosciences make money?
Three revenue lines are on record. Microfluidic Instruments are the primary driver. The others are consumables and Kits and proof of Concept Services.
Who are Atrandi Biosciences's main competitors?
Direct peers on record are 10x Genomics, Standard BioTools (formerly Fluidigm, merged with PhenomeX/Berkeley Lights), Parse Biosciences, Mission Bio, Sphere Bio and Dolomite Bio (Blacktrace Holdings). Broad incumbents are Bio-Rad Laboratories, BD Biosciences and Bruker (acquired NanoString). 1CellBio (now part of Cantata Bio) is listed as an emerging player.
Does Atrandi Biosciences have an API?
No public API is recorded for Atrandi Biosciences.
What industry is Atrandi Biosciences in?
Atrandi Biosciences's product category is Microfluidic Single-Cell Analysis Instruments. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 334516 and its SIC code is 3826.